Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceuti... IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. Show more
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos...
Revenue of $3,896 million GAAP Net Income of $285 million, Adjusted EBITDA of $939 million GAAP Diluted Earnings per Share of $1.55, Adjusted Diluted Earnings per Share of $2.84 R&D...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a...
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA...
Award Recognizes Leadership in AI Regulatory and Quality Solutions for Healthcare IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research...
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative PR Newswire PHILADELPHIA, Sept. 4, 2024 PHILADELPHIA, Sept. 4, 2024 /PRNewswire/...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 14.97 | 7.91854006876 | 189.05 | 206.96 | 189.05 | 2323309 | 197.15501439 | CS |
| 4 | -12.39 | -5.72524375029 | 216.41 | 225.91 | 187.62 | 2313700 | 205.04870261 | CS |
| 12 | -45.01 | -18.0741276151 | 249.03 | 252.69 | 187.62 | 1516729 | 219.55949837 | CS |
| 26 | -25.77 | -11.2145872318 | 229.79 | 252.88 | 187.62 | 1323359 | 222.92543391 | CS |
| 52 | -6.75 | -3.20254305641 | 210.77 | 261.73 | 187.62 | 1151723 | 225.99381042 | CS |
| 156 | -58.495 | -22.282536236 | 262.515 | 285.61 | 165.75 | 1097720 | 218.16914918 | CS |
| 260 | 57.96 | 39.6823223333 | 146.06 | 285.61 | 81.79 | 1107387 | 199.93063559 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
